Why clinics offering stem cell therapies need a caution sign – The Olympian
The Olympian |
Why clinics offering stem cell therapies need a caution sign
The Olympian A staggering 54 million Americans suffer from some form of arthritis. Millions more have muscle, tendon or ligament injuries. Short of surgery, physicians usually focus on controlling pain and inflammation, which doesn’t always resolve these problems … Global Stem Cell Banking Market Forecast 2018-2023: PBKM FamiCord, cells4life, Cordlife Group, Crioestaminal and …News of Observer |
Burnett County Sentinel |
Second Outdoorsman’s Dream Raffle set to fund stem cell treatment
Burnett County Sentinel Christensen has devoted his entire life to helping others. He has been an amazing influence on many troubled young adults. Proceeds from the raffle on Feb. 14 will go towards a trip to Panama for more stem cell treatments. ×. 9 remaining of 10. Welcome … |
|
Gene Therapy in Muscular Dystrophy
Muscular Dystrophy News Dystrophin is part of a protein complex that strengthens and protects muscle fibers. When the cells don’t have functional dystrophin due to the gene mutation, muscles progressively weaken. Scientists think that supplying a gene that codes for a … |
|
BMS Immunotherapy Combo Study Backs FoundationOne CDx Tumor Mutational Burden Indication
360Dx NEW YORK (GenomeWeb) – A study evaluating the combination of Bristol-Myers Squibb’s immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) may support regulatory approval for the regimen as an option for lung cancer patients with a large number of … |
|
BMS Immunotherapy Combo Study Backs FoundationOne CDx Tumor Mutational Burden Indication
360Dx NEW YORK (GenomeWeb) – A study evaluating the combination of Bristol-Myers Squibb’s immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) may support regulatory approval for the regimen as an option for lung cancer patients with a large number of … |
Medical Xpress |
New immunotherapy combination tolerable, effective in patients with advanced kidney cancer
Medical Xpress The immunotherapy agent, pembrolizumab, is an immune checkpoint inhibitor that blocks a self-defense mechanism used by cancer cells to evade attack and destruction by the body’s immune cells. It is FDA-approved for the treatment of patients with … New combo therapy found effective in kidney cancer patientsDaijiworld.com |